Seasonal Allergic Rhinitis In Pediatric Subjects

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 3

Conditions: Rhinitis, Allergic, Perennial

Treatments: Drug: GW685698X

Study type: Interventional

Funder types: Industry

Identifiers

NCT00107757

FFR100010

Details and patient eligibility

About

The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.

Sex: All

Ages: 2 to 12 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of seasonal allergic rhinitis.
• Adequate exposure to seasonal (Spring/Summer) allergen prevalent to the geographic area.

Exclusion criteria

• Have significant concomitant medical conditions.
• Use of corticosteroids, other allergy meds during the study.
• Have abnormal ECG or laboratory abnormality.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind